Pharmacogenomics of NAT2 and ABCG2 influence the toxicity and efficacy of sulphasalazine containing DMARD regimens in early rheumatoid arthritis

M Wiese, N Alotaibi, Catherine O'Doherty, Michael Sorich, V Suppiah, Leslie Cleland, S Proudman

    Research output: Contribution to journalArticlepeer-review

    19 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Pharmacogenomics of NAT2 and ABCG2 influence the toxicity and efficacy of sulphasalazine containing DMARD regimens in early rheumatoid arthritis'. Together they form a unique fingerprint.

    Medicine & Life Sciences